Thrivent Financial For Lutherans Ardelyx, Inc. Transaction History

Thrivent Financial For Lutherans

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$1.27 - $8.17 $2.43 Million - $15.7 Million	-1,915,942 Closed	0 $0
Q2 2021 Aug 19, 2021	SELL	$6.55 - $8.98 $3.4 Million - $4.66 Million	-518,987 Reduced 21.31%	1,915,942 $14.5 Million
Q1 2021 May 17, 2021	BUY	$6.1 - $7.69 $2.2 Million - $2.77 Million	360,514 Added 17.38%	2,434,929 $16.1 Million
Q4 2020 Feb 16, 2021	BUY	$5.05 - $7.1 $10.5 Million - $14.7 Million	2,074,415 New	2,074,415 $13.4 Million
Q3 2019 Nov 14, 2019	SELL	$2.15 - $6.28 $156,246 - $456,386	-72,673 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$3.7 - $5.8 $268,890 - $421,503	72,673 New	72,673 $269,000

218

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $787M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

Stay updated on Thrivent Financial For Lutherans with notifications on news.